Gildi - lifeyrissjodur reported 2 positions worth $197.19M for the quarter ended Mar 31, 2026, down 10.8% on the prior quarter. It opened 0 new positions, added to 0, trimmed 2 and exited 0. Its largest holding is JBT MAREL Corp at 67.4% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
No positions were added to this quarter.
No new positions this quarter.
No positions were closed this quarter.
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | JBTM JBT MAREL Corp | Industrials | 1.07M | $132.87M | 67.38% | -42.2K | -3.8% | Reduced | 2.04% |
| 2 | OCS Oculis Holding AG | Healthcare | 2.43M | $64.32M | 32.62% | -17.6K | -0.7% | Reduced | 4.65% |
Tip. Select a row to see that position’s full history at Gildi - lifeyrissjodur.
As of its Q1 2026 13F filing, Gildi - lifeyrissjodur’s five largest positions were JBT MAREL Corp (JBTM) at 67.4%, Oculis Holding AG (OCS) at 32.6% of the reported portfolio.
Gildi - lifeyrissjodur reported a 13F portfolio worth $197.19M across 2 positions for Q1 2026. That is down 10.8% from the previous quarter.
Its largest sales by value were JBT MAREL Corp ($5.26M), Oculis Holding AG ($465.33K). It exited 0 positions entirely.
From the Form 13F-HR reports Gildi - lifeyrissjodur files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.